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Activation of NF-B by Double-Stranded RNA (dsRNA) in the
Absence of Protein Kinase R and RNase L Demonstrates the
Existence of Two Separate dsRNA-Triggered
Antiviral Programs
MIHAIL S. IORDANOV,1 JOHN WONG,1 JOHN C. BELL,2,3

AND

BRUCE E. MAGUN1*

Department of Cell and Developmental Biology, Oregon Health Sciences University, Portland, Oregon 97201,1 and
Ottawa Regional Cancer Center Research Laboratories, Ottawa, Ontario K1H 8L6,2 and Department
of Biochemistry, University of Ottawa, Ottawa, Ontario K1H 8M5,3 Canada

Double-stranded RNA (dsRNA) of viral origin triggers two programs of the innate immunity in virusinfected cells. One is intended to decrease the rate of host cell protein synthesis and thus to prevent viral
replication. This program is mediated by protein kinase R (PKR) and by RNase L and contributes, eventually,
to the self-elimination of the infected cell via apoptosis. The second program is responsible for the production
of antiviral (type I) interferons and other alarmone cytokines and serves the purpose of preparing naive cells
for the viral invasion. This second program requires the survival of the infected cell and depends on the
expression of antiapoptotic genes through the activation of the NF-B transcription factor. The second
program therefore relies on ongoing transcription and translation. It has been proposed that PKR plays an
essential role in the activation of NF-B by dsRNA. Here we present evidence that the dsRNA-induced NF-B
activity and the expression of beta interferon and inflammatory cytokines do not require either PKR or RNase
L. Our results indicate, therefore, that the two dsRNA-activated programs are separate and can function
independently of each other.

are the dsRNA-activated protein kinase (PKR) and the coupled 2-5 oligoadenylate synthase/RNase L system. PKR (39) is
a dormant enzyme directly activated by binding of dsRNA (for
recent reviews, see references 28 and 73). A major substrate of
PKR is the ␣-subunit of the eukaryotic translation initiation
factor 2 (eIF-2␣) (22, 35). Phosphorylation of eIF-2␣ greatly
reduces the rate of initiation of translation (50). The 2-5 oligoadenylate synthase/RNase L system is composed of a family
of dsRNA-dependent enzymes known as 2⬘-5⬘ oligoadenylate
synthetases (OAS) (7, 24, 43) and the dormant cytosolic RNase
L (82). Upon dsRNA binding, OAS produce unusual second
messengers, short 2⬘-5⬘-linked oligoadenylates (2-5A), which,
in turn, specifically bind to and activate RNase L (41). Activated RNase L cleaves diverse RNA substrates, including 18S
and 28S rRNA, thus inhibiting cellular protein synthesis (26,
51, 52, 74). Fibroblasts from mice nullizygous for both PKR
and RNase L alleles are unable to inhibit protein synthesis
when challenged with dsRNA (26), thus demonstrating that
these two enzymes are both required and sufficient for the
translational inhibition caused by dsRNA. Recently, both PKR
(2, 3, 15, 20, 34, 53, 77) and RNase L (7–9, 13, 83, 85) have
been found to mediate dsRNA-induced apoptosis. The mechanisms of involvement of PKR and RNase L in the dsRNAtriggered apoptosis are, however, poorly understood. Considering the role of both PKR and RNase L in inhibiting protein
synthesis, one obvious candidate for a death-inducing signal is
the impaired process of translation. A sustained inhibition of
protein synthesis is sufficient to trigger apoptosis in cells in a
way that is independent of the particular means of achieving
translational inhibition (27). However, other (more direct)

At the cellular level, the innate immune response to viruses
relies on the execution of two apparently conflicting cellular
programs: cell suicide (apoptosis) and survival. The first program is probably most efficient for viral infections that are
initiated by a small number of infected cells at a local site of
virus entry. In such case, it seems beneficial (for the organism)
for this first population of infected cells to undergo a rapid
process of self-elimination through apoptosis, thus preventing
further infection. That this first line of antiviral defense is
widely used is evident from the multitude of antiapoptotic
strategies employed by viruses. Viral genomes encode a growing number of apoptosis-inhibiting proteins, such as the adenovirus E1B protein (45, 72), the baculovirus p35 protein (5,
44, 58), the cowpox virus CrmA protein (17, 63), the poxvirus
and gammaherpesvirus v-FLIP proteins (66), and others (for a
review, see reference 62). Genetic evidence from mice (48)
(see below) demonstrates that inhibition of apoptosis by the
virus is critical for the virulence of encephalomyocarditis virus
(EMCV), a picornavirus that is lethal to infected mice.
A common viral intermediate that is recognized by specific
cellular sensory systems to trigger apoptosis is viral doublestranded RNA (dsRNA). The best-characterized effect of
dsRNA on cells is the inhibition of protein synthesis in host
cells. The cellular dsRNA-detecting systems that are responsible for the translational inhibition in response to viral infection
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products of the p50/p105(nfkb1), p52/p100(nfkb2), c-rel, relA,
and relB genes (for reviews, see references 21 and 42). In
mammalian cells, the most common NF-B complex is the
p50/NF-B1–p65/RelA heterodimer, and it is this combination
that is most commonly referred to as NF-B proper (42). An
essential role in the regulation of NF-B is played by a family
of inhibitory proteins, collectively termed IBs (the family encompasses IB-␣, IB-␤, IB-ε, and Bcl-3 [for a review, see
reference 31]). In nonstimulated cells, IBs sequester the p50/
NF-B1–p65/RelA heterodimer in the cytoplasm, thus preventing it from localizing in the nucleus and stimulating the
transcription of NF-B-dependent genes (for a review, see
reference 31). With the notable exception of UV radiation, a
potent NF-B activator, most stimuli that activate NF-B (including viruses and dsRNA) cause the phosphorylation of
serine residues 32 and 36 in IB-␣ (and of the corresponding
serine residues in IB-␤). The phosphorylation of IB causes
its rapid polyubiquitinylation and degradation by the 26S proteasome, thus releasing NF-B and allowing it to translocate to
the nucleus (most extensively reviewed in references 30, 31,
and 80). A multicomponent IB kinase (IKK) complex has
been purified, molecularly cloned, and found to consist of two
homologous catalytic subunits (IKK1/␣ and IKK2/␤) (14, 38,
81) and a noncatalytic subunit (IKK␥, also known as NEMO)
(75). Genetic inactivation of IKK in mice demonstrated that
IKK2/␤ and IKK␥ (but not IKK1/␣) are required for the IB
phosphorylation and subsequent NF-B activation in response
to most agents (25, 36, 46, 59, 61). Due to the lack of suitable
targeted gene inactivation models, however, the modes of upstream regulation of IKK activity are currently completely unknown, even though several kinases have been proposed to act
upstream of IKKs. For instance, in striking contrast to all
experimental evidence concerning the role of PKR in triggering the protein synthesis-inhibiting and proapoptotic program
of antiviral innate immunity, this kinase has been proposed to
be a major mediator of virus- and dsRNA-induced activation
of NF-B. Using mouse embryonic fibroblasts (MEF) and 3T3like fibroblast cell lines from one of the two published PKR
genetic knockouts (76), several groups found these cells to be
deficient in dsRNA-induced NF-B activation, thus postulating an important role for this kinase in activating NF-B in
response to viruses (11, 19, 79).
We considered that this postulated role of PKR in dsRNAinduced NF-B activation ultimately imposes the paradoxical
situation that the same dsRNA-sensing molecule (PKR) would
trigger the execution of the two opposing antiviral programs in
the same cell: the program that attempts to eliminate the
infected cell through translational inhibition and apoptosis and
the program that attempts to suppress apoptosis through
NF-B activation. To resolve this paradox, we have employed
a panel of primary MEF or 3T3-like cell lines from two independent successful attempts to inactivate the PKR gene in
mice (1, 76), from the RNase L-deficient mice (83), and from
mice with a double deficiency in both the PKR and the RNase
L genes (26, 84). Our study demonstrates that neither PKR nor
RNase L is required for the activation of NF-B by dsRNA or
EMCV. Furthermore, we found that the ability of dsRNA to
stimulate the expression of beta interferon and of the inflammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-␣) was also independent of the presence of
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mechanisms of dsRNA-induced cell death, which are independent of the state of cellular translation, are very likely to exist.
The second dsRNA-initiated program for antiviral defense
involves the production and secretion by the infected cells of
alarmone cytokines, the best-studied examples of which are the
alpha, beta, and omega interferons, [for reviews, see references
16 and 54]). The importance of these interferons for conferring
viral resistance to naive cells has been demonstrated by the
strong sensitivity to viral infections of mice lacking the common subunit of the alpha, beta, and omega interferon receptor
(40). It is thought that these interferons exert their pleiotropic
antiviral actions by preparing cells to interfere with multiple,
virus-specific steps of the viral replication cycle, including viral
entry, uncoating, transcription, RNA stability, maturation, assembly, and release (for a review, see reference 54). Interferons are also important for the ability of adaptive immunity to
take over the innate immune response in combating the virus.
For instance, mice lacking the interferon alpha, beta, and
omega receptor are unable to mount a cytotoxic T-lymphocyte
response to infection with lymphocytic choriomeningitis virus
(40).
A crucial step in the virus-induced beta interferon production appears to be its transcriptional upregulation by viral
dsRNA (for a review, see reference 37). The highly specific
transcriptional induction of the beta interferon gene by viruses
has been best studied for the human beta interferon gene
promoter/enhancer region. This region contains a set of regulatory elements called positive regulatory domains (PRDI to
PRDIV). PRDII, PRDI-III, and PRDIV bind the transcription
factors NF-B, IRF-1 (or IRF-3), and ATF-2/c-Jun, respectively (for a review, see reference 37). Importantly, NF-B
appears to be absolutely required for the virus-induced activation of the human beta interferon promoter (18, 64, 65).
For the second (interferon-dependent) program of innate
antiviral immune response to be successful, the proapoptotic
response of the infected cells must be suppressed, at least for
the time required to complete the production and secretion of
alarmone cytokines. Interestingly, genetic evidence strongly
suggests that NF-B not only plays an important role in the
production of beta interferon but also is essential in suppressing virus-induced apoptosis. Mice engineered to lack the p50/
NF-B1 subunit of NF-B (see below) are resistant to infection with EMCV (48, 49). This surprising result (which seems
to contradict the important role of NF-B in combating viral
infections) is explained by the discovery that EMCV-infected
cells from p50/NF-B1-nullizygous mice (as well as from mice
engineered to lack the other common subunit of NF-B, p65/
RelA [see below]) undergo very rapid apoptosis before the
virus could reproduce (48). These results demonstrate the apoptosis-suppressing function of NF-B in EMCV infection.
The antiapoptotic role of NF-B is thought to result from the
NF-B-dependent transcriptional activation of several apoptosis-inhibiting genes, such as the genes encoding the inhibitorof-apoptosis proteins (IAPs; for a review, see reference 32)
IAP-1, IAP-2, and X-linked IAP (X-IAP1) (12, 55, 70), Bcl-XL
(10, 33, 68), and A1/Bfl1 (33, 57, 69, 86).
How is NF-B activated in general and by viruses and
dsRNA in particular? NF-B is a collective name for a group
of homo- and heterodimeric transcriptional regulators (activators or repressors) consisting in vertebrates, of the polypeptide
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PKR. Thus, the “translational inhibition/pro-apoptotic program” and the “biosynthetic/anti-apoptotic program,” each
triggered by viral dsRNA, appear to be mechanistically separate and to function independently of one another.
MATERIALS AND METHODS

(10 mM HEPES [pH 7.9], 1 mM EDTA, 60 mM KCl, 0.5% Nonidet P-40
[NP-40], 1 mM dithiothreitol [DTT], protease inhibitor cocktail [Roche Molecular Biochemicals]). After 5 min on ice, nuclei were sedimented at 1,200 ⫻ g for
5 min. The supernatant was used as the cytoplasmic extract. The nuclei were
washed with lysis buffer without NP-40 and suspended in 100 l of nuclear buffer
(250 mM Tris-HCl [pH 7.8], 60 mM KCl, 1 mM DTT, protease inhibitor cocktail). Nuclei were lysed by three cycles of freezing and thawing in liquid nitrogen
and ice. The nuclear extracts were cleared by centrifugation at 13,000 ⫻ g for 15
min. EMSAs were done as described in reference 4: the binding reaction was
performed in a volume of 20 l with 5 g of nuclear protein in a buffer containing
12 mM HEPES (pH 7.8), 62.5 mM Tris-HCl (pH 7.8), 60 mM KCl, 0.6 mM
EDTA, 12% glycerol, 5 mM DTT, 2 g of bovine serum albumin, and 1 g of
poly(dI-dC). 32P-radiolabeled consensus double-stranded NF-B-binding oligonucleotide (5⬘-AGT TGA GGG GAC TTT CCC AGG C-3⬘) or the corresponding oligonucleotide with a single-base point mutation (5⬘-AGT TGA GGC GAC
TTT CCC AGG C-3⬘) from Santa Cruz Biotechnologies were used as probes.
For the competition experiments, a consensus double-stranded p53-binding oligonucleotide (5⬘-TAC AGA ACA TGT CTA AGC ATG CTG GGG-3⬘) from
Santa Cruz Biotechnologies was used as a nonspecific competitor.
RNA isolation and Northern blot detection of mRNA. Total cellular-RNA was
isolated using TRIzol reagent (GIBCO BRL) as specified by the manufacturer.
The multiprobe detection of beta interferon, IL-6, and TNF-␣ was performed
using a RiboQuant RNase protection assay kit with a mCK-3b multiprobe template (Pharmingen) as specified by the manufacturer. A 10-g portion of total
RNA was used.
Determination of IL-6 production. The production of IL-6 was determined
quantitatively using the Quantikine M mouse IL-6 enzyme-linked immunosorbent assay (R&D Systems) as specified by the manufacturer and as described
previously (26).

RESULTS
EMCV infection causes the proteolytic degradation of IB-␤
in both pkrⴙ/ⴙ and pkr0/0 MEF. To investigate the possible role
of PKR in virus-induced activation of NF-B, we employed
primary fibroblasts derived from wild-type (pkr⫹/⫹) or pkr0/0
mouse embryos established in the laboratory of one of us (1).
Since the inactivation of PKR alleles in these mice was
achieved through a homologous recombination event involving
exon 12 of the PKR gene, these MEF are referred to hereafter
as pkr⫹/⫹(EX12) and pkr0/0(EX12), respectively. Later, when
MEF from a different PKR knockout (inactivating the PKR
gene exons 2 and 3) (76) are used (see below), these cell will be
referred to as pkr⫹/⫹(EX2⫹3) and pkr0/0(EX2⫹3), respectively. At 2 h after infection with EMCV, there was a detectable decrease in the steady-state levels of IB-␤ both in the
pkr⫹/⫹(EX12) and in the pkr0/0(EX12) MEF (Fig. 1A, lanes 3
and 7). Four hours after the infection, IB-␤ levels in both the
pkr⫹/⫹(EX12) and the pkr0/0(EX12) MEF were reduced to a
minor fraction of those in the control cells (compare lanes 2
and 6 with lanes 4 and 8). The absence of PKR in the pkr0/0
(EX12) MEF was confirmed using two independent PKR antisera (compare lanes 1 to 4 with lanes 5 to 8). At 4 h after the
infection with EMCV, the levels of PKR in the wild-type MEF
were reduced (lane 4), probably reflecting the overall inhibition of protein synthesis and the subsequent turnover of PKR
protein in these cells.
dsRNA triggers the phosphorylation, polyubiquitinylation,
and proteosome-mediated degradation of IBs in both pkrⴙ/ⴙ
(EX12) and pkr0/0(EX12) MEF. The degradation of IB-␤ in
EMCV-infected MEF was paralleled by the phosphorylation
of the stress-activated protein kinases (SAPK) p38␣ MAP kinase (Fig. 1A, lanes 3, 4, 7, and 8), JNK1, and JNK2 (not
shown). Previously, we reported that SAPK are potently activated by dsRNA (26). We set out, therefore, to investigate the
specific role of dsRNA in virus-induced activation of NF-B,
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Chemicals. Lipofectin reagent was from Gibco BRL/Life Technologies. pI-pC
was from Midland Certified Reagent Co. and was stored at ⫺20°C as a 10-mg/ml
stock solution in double-distilled deionized water. The proteasome inhibitors
benzyloxycarbonylleucyl-leucyl-leucine aldehyde (MG 132) and benzyloxycarbonyliso-leucyl-glutamyl(OtBu)-alanyl-leucine aldehyde (proteasome inhibitor
I) were purchased both from Alexis Biochemicals and from Calbiochem, and
there was no detectable difference in their activities. Recombinant human
TNF-␣ was from R&D Systems. All radiochemicals were from DuPont NEN
Research Products.
Cells. All cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% calf serum (HyClone, Logan, Ut.). pkr⫹/⫹
(EX12) and pkr0/0(EX12) MEF have been described previously (1) and were
referred to there as pkr⫹/⫹ and pkr0/0 cells. pkr⫹/⫹(EX2⫹3) and pkr0/0(EX2⫹3)
MEF were described previously (76) and were also referred to there as pkr⫹/⫹
and pkr0/0 cells. The rnasel⫹/⫹/pkr⫹/⫹, rnasel⫺/⫺/pkr⫹/⫹, and rnasel⫺/⫺/pkr⫺/⫺
3T3-like fibroblasts were described previously (84) and are referred to here by
the same names as in reference 26.
Lipofectin-mediated delivery of pI-pC. The procedure for treatment of cells
with pI-pC was the same as described in reference 26. For each milliliter of final
volume of Lipofectin mixture, an initial concentrated mixture (containing Lipofectin and pI-pC) was prepared in one-quarter of the final volume (250 l). To
this end, 10 l of Lipofectin (1 mg/ml) was added to serum- and antibiotic-free
DMEM and mixed, and the desired amount of pI-pC was added (in a volume of
250 l). This mixture was left for 10 min at room temperature. Finally, the
remaining three-quarters of the final volume (750 l) was added. Before the
application of the Lipofectin–pI-pC mixtures, the cells were washed once with
serum-free DMEM.
Preparation of cell lysates for immunoblot analysis. To avoid any possible
dephosphorylation or proteolytic degradation of the proteins of interest, the cells
were typically harvested by aspirating the cell culture medium, scraping the cells
directly on the tissue culture plate in 2⫻ sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) sample-loading buffer, and subjecting them to
heat denaturation at 95°C for 5 min. Cell lysates were stored at ⫺70°C.
Antibodies and immunoblot analyses. The antibodies against IB-␤ (C-20),
phospho-(serine-32)–IB-␣ (B-9), PKR (M-515 and D-20), and p65/RelA (C-20)
and the blocking peptide solutions used in the experiment in Fig. 3 (p65/RelA
C-20 peptide and MEKK1 C-22 peptide) were from Santa Cruz Biotechnologies.
For the antibody blocking, 1 volume of the anti-p65/RelA antibody was preincubated with 5 volumes of the respective blocking peptide solution for 6 h at
room temperature. The antibody against IB-␣ (13996E) was from Pharmingen.
The antibodies against the dually phosphorylated forms of JNK and p38␣ mitogen-activated protein (MAP) kinase were from New England BioLabs. The
antibody against the phosphorylated form of eIF-2␣ was from Research Genetics. The electrophoretic separation of proteins in SDS-PAGE and electrotransfer
to a polyvinylidene difluoride membrane (Millipore) were performed using standard procedures. Immunoprobing with specific antibodies and enhanced chemiluminescence detection (DuPont NEN Research Products) were performed as
specified by the respective manufacturers.
Immunocytochemical staining of p65/RelA. Cells were grown on Thermanox
coverslips (Nunc). After the appropriate treatments, the cells were fixed in cold
(⫺20°C) methanol for 5 min, dried, and stored at ⫺20°C. Blocking was performed with 1.5% normal goat serum in PBS for 1 h followed by incubation with
the primary antibody (anti-p65/RelA [C-20 from Santa Cruz] at a 1:800 dilution
in PBS with 1.5% serum) for 1 h. After the cells were washed in PBS, incubation
with secondary antibody was performed with biotinylated anti-rabbit immunoglobulin G (1:500 dilution in PBS with 1.5% serum) for 1 h, followed again by
washing. Endogenous peroxidase activity was quenched with 2% hydrogen peroxide in PBS for 30 min. After being washed, the cells were incubated with
VectaStain Elite ABC reagent (Vector Laboratories) for 1 h. Finally, the cells
were washed, incubated with diaminobenzidine (Sigma) until the desired stain
intensity developed, and rinsed with water. Photographs were taken using a
CoolSnap digital camera mounted on a Zeiss microscope.
EMSA. Nuclear extracts were prepared and used in electrophoretic mobility
shift assays as described in references 4 and 56. Briefly, cells were collected by
scraping in ice-cold PBS, sedimented, and resuspended in 100 l of lysis buffer
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independent of viral proteins that, in many cases, also modulate NF-B activity. To achieve this goal, we used pI-pC, a
synthetic dsRNA, which was delivered into cells via lipofection
(see Materials and Methods). First, we set out to confirm that
the deletion of exon 12 of PKR in the pkr0/0(EX12) MEF
resulted in a complete abrogation of PKR activity. Treatment
of pkr⫹/⫹(EX12) MEF with pI-pC (hereafter referred to as
dsRNA) caused the phosphorylation of eIF-2␣ at serine-51
(Fig. 1B, lane 3). Identically treated pkr0/0(EX12) MEF failed
to display the phosphorylation of eIF-2␣ at serine-51 (lane 6).
In contrast to these results and in agreement with our previous
findings (26), the p38␣ MAP kinase was phosphorylated in
response to dsRNA both in the PKR-containing and in the
PKR-deficient cells (lanes 3 and 6). We concluded, therefore,

FIG. 2. dsRNA-triggered phosphorylation, polyubiquitinylation,
and proteosome-mediated degradation of IBs in both pkr⫹/⫹(EX12)
and pkr0/0(EX12) MEF. (A) pkr⫹/⫹(EX12) and pkr0/0(EX12) MEF
were treated with Lipofectin alone (lanes Control) or with pI-pC (10
g/ml) in the presence of Lipofectin (lanes dsRNA). Note that the
same procedure for Lipofectin treatment (with or without pI-pC) applies to all experiment presented in Fig. 2 to 9 and is described in
Materials and Methods. At 1 h after the treatment, the cells were
harvested and processed for immunoblot analysis of IB␣ using either
a phospho-(Ser32)-IB␣-specific antibody (upper panels) or an IB␣specific antibody (lower panels). Treatment of cells with Lipofectin
does not affect IB␤ or any other NFB-related signaling pathway
investigated in this work (data not shown). (B) pkr⫹/⫹(EX12) and
pkr0/0(EX12) MEF were treated as in panel A, except that, where
indicated, the cells were pretreated for 25 min with benzyloxycarbonyliso-leucyl-glutamyl(OtBu)-alanyl-leucine aldehyde (IEAL), benzyloxycarbonyl-leucyl-leucyl-leucine aldehyde (LLL), or the respective
solvents for each of them, methanol (MeOH) or dimethyl sulfoxide
(DMSO). IB␤ steady-state levels were monitored in an immunoblot
analysis.

that the deletion of exon 12 of PKR in the pkr0/0(EX12) MEF
has resulted indeed in a complete abrogation of PKR activity.
We next addressed the dsRNA-induced signaling to NF-B.
Treatment of either pkr⫹/⫹(EX12) or pkr0/0(EX12) MEF with
pI-pC for 1 h resulted in a detectable increase in serine-32
phosphorylation of IB-␣ as measured by immunoblot analysis
using an antibody recognizing specifically only the serine-32phosphorylated form of IB-␣ (Fig. 2A, upper panels, lanes 2
and 4). Consistent with the role of IB-␣ phosphorylation in its
degradation by the ubiquitin-proteosome system (for a review,
see reference 31), the levels of IB-␣ were significantly reduced in dsRNA-treated cells (lower panels, lanes 2 and 4). To
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FIG. 1. (A) EMCV-induced degradation of IB-␤. pkr⫹/⫹(EX12)
and pkr0/0(EX12) MEF (⬃2 ⫻ 106 cells) were infected, where indicated, with EMCV (100 PFU per cell) in 2 ml of serum-free medium
for 1 h, after which time the excess virus was removed by extensive
washing of the cells with serum-free medium. The cells were further
incubated in serum-free medium. At 2 or 4 h after the removal of the
extracellular virus, the mock-infected or infected cells were harvested
and the cell lysates were processed for the immunoblot detection of
IB-␤ (top panel) as described in Materials and Methods. The membranes were stripped and reprobed consecutively with an anti-phosphorylated p38 MAP kinase antibody (second panel from top) and
with the M-515 (third panel from top) and D-20 (bottom panel) PKR
antisera. A nonspecific band recognized by the D-20 antibody is indicated by an asterisk. (B) Lack of PKR activity in the pkr0/0(EX12)
MEF. pkr⫹/⫹(EX12) and pkr0/0(EX12) MEF were left untreated (Co)
or were treated with Lipofectin (LF) alone or with pI-pC (10 g/ml) in
the presence of Lipofectin (LF ⫹ dsRNA). At 3 h after the treatments,
the phosphorylation states of eIF-2␣ and p38␣ MAP kinase were
assessed in immunoblot analyses.
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FIG. 3. dsRNA-induced nuclear translocation of NFB. pkr⫹/⫹
(EX12) MEF were treated with Lipofectin alone (A, C, and E) or with
pI-pC (10 g/ml) in the presence of Lipofectin (B, D, and F). At 3 h
after the treatment, the cells were fixed and immunostained with an
antibody recognizing the p65/RelA subunit of NFB, as described in
Materials and Methods. An irrelevant peptide (representing an
epitope corresponding to the C-terminal domain of MEKK1) or a
specific blocking peptide were used (as described in Materials and
Methods) in panels E and F and in panels C and D, respectively.

3E and 3F). An identical pattern of nuclear staining was detected after treatment of cells with TNF-␣ (data not shown).
Thus, the method used in the experiment in Fig. 3 appeared to
represent faithfully the translocation of p65/RelA following a
signal that triggers IB degradation. Using this method, we
next demonstrated that, both in the pkr0/0(EX2⫹3) MEF and
in the pkr0/0(EX12) MEF, dsRNA led to a nuclear translocation of p65/RelA in a manner identical to the ability of dsRNA
to cause p65/RelA nuclear translocation in the respective wildtype cells (Fig. 4). Thus, the evidence obtained using MEF
from two independent approaches to generate PKR-null mice
demonstrates that PKR is not an essential kinase for the migration of NF-B to the nucleus following dsRNA-induced IB
degradation.
PKR deficiency does not affect the specific DNA-binding
activity of NF-B. Since a fraction of PKR has been found in
the nucleus (29), it was not unreasonable to investigate
whether PKR might be involved in modulating NF-B activity
at the level of the DNA-binding ability of this transcription
factor. Nuclear extracts from wild-type MEF (EX12) treated
with either dsRNA or TNF-␣ displayed a prominent DNA-
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investigate whether IB-␤ is also degraded by the ubiquitinproteosome system in response to dsRNA, we employed two
peptide proteosome inhibitors, benzyloxycarbonylleucyl-leucylleucine aldehyde (labeled LLL in Fig. 2B) and benzyloxycarbonyliso-leucyl-glutamyl(OtBu)-alanyl-leucine aldehyde
(labeled IEAL in Fig. 2B). Treatment of either pkr⫹/⫹(EX12)
or pkr0/0(EX12) MEF with dsRNA for 1 h led to a detectable
reduction in the steady-state levels of IB-␤ in both the pkr⫹/⫹
(EX12) and the pkr0/0(EX12) MEF (Fig. 2B, narrow panels,
lane 6). Pretreatment of the cells with either of the two proteosome inhibitors prevented the dsRNA-induced degradation
of IB-␤ (narrow panels, lanes 9 and 10). Furthermore, in the
presence of both dsRNA and the proteasome inhibitors, the
cells accumulated multiple anti-IB-␤-immunoreactive bands
with reduced mobility in SDS-PAGE (wide panels, lanes 9 and
10; note that the wide panels represent a longer film exposure
of the same immunoblots presented in the narrow panels). The
appearance of these novel forms of anti-IB-␤ immunoreactivity with reduced mobility is consistent with unimpaired levels
of dsRNA-induced polyubiquitinylation of IB-␤ but a blocked
polyubiquitinylation-induced degradation of IB-␤ by the proteasome. Importantly, identical effects on the IBs of these
proteasome inhibitors were observed in cells stimulated with
TNF-␣, a well-established inducer of proteasome-mediated
degradation of IBs (reference 67 and data not shown). None
of the dsRNA-induced effects on IBs (phosphorylation,
polyubiquitinylation, and proteasome-dependent degradation)
appeared to require the presence of PKR. Neither singlestranded RNA (pI or pC), nor dsDNA (p[d(IC)]) had any
effect on IB-␤ or IB-␣ (data not shown), indicating that the
effects observed using pI-pC represent a bona fide dsRNA
response. Despite the limited ability to compare the behavior
of IB-␤ and IB-␣ in the same assay, the results shown in Fig.
2 favor the conclusion that both IBs are addressed by dsRNAinduced signal transduction pathways in a similar manner.
dsRNA-induced IB degradation coincides with translocation of NF-B to the nucleus, independent of the presence or
the absence of PKR. To investigate and determine conclusively
if PKR may be required for a functional activation of NF-B
downstream of IB phosphorylation and degradation, we employed pkr⫹/⫹(EX12) and pkr0/0(EX12) MEF and pkr⫹/⫹
(EX2⫹3) and pkr0/0(EX2⫹3) MEF (76). First, we demonstrated that in the pkr⫹/⫹(EX2⫹3) and pkr0/0(EX2⫹3) MEF,
the Lipofectin-mediated delivery of dsRNA led to the degradation of IB-␣ and IB-␤ similarly to the effect of dsRNA on
the pkr⫹/⫹(EX12) and pkr0/0(EX12) MEF [data not shown, but
see also Fig. 8, demonstrating the dsRNA-induced IB-␤ degradation in embryonic fibroblasts derived from pkr0/0(EX2⫹3) ⫻
rnasel⫺/⫺ mice (84)]. We then performed immunocytochemical
staining of control (Lipofectin-treated) and dsRNA-treated
MEF (EX12 and EX2⫹3) by using an antibody recognizing the
p65/RelA subunit of NF-B. As shown in Fig. 3A, p65/RelA
displayed a typical cytoplasmic distribution in the control
pkr⫹/⫹(EX2⫹3) MEF. At 3 h after dsRNA treatment, a strong
immunopositive signal appeared in the nucleus (Fig. 3B), indicative of induced nuclear translocation of NF-B. Preincubation of the antibody with a p65/RelA peptide epitope abolished the immunocytochemical staining (Fig. 3C and D),
whereas the preincubation with an irrelevant peptide epitope
had no effect on the ability of the antibody to stain cells (Fig.
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FIG. 4. dsRNA-induced nuclear translocation of NFB independent of the presence or the absence of PKR. pkr⫹/⫹(EX2⫹3), pkr0/0
(EX2⫹3), pkr⫹/⫹(EX12), or pkr0/0(EX12) MEF were treated with Lipofectin alone (A, C, E, and G) or with pI-pC (10 g/ml) in the
presence of Lipofectin (B, D, F, and H). At 3 h after the treatment, the
cells were fixed and immunostained with an antibody recognizing the
p65/RelA subunit of NFB as in Fig. 3.

binding activity in EMSA using an NF-B-specific oligonucleotide probe (Fig. 5, lanes 1 to 3). This DNA-binding activity
was successfully competed by a 100-fold molar excess of the
same unlabeled probe (lanes 4 to 6) but was not competed by
a 100-fold molar excess of an irrelevant oligonucleotide (lanes
7 to 9). Furthermore, the DNA-binding activity was supershifted when the nuclear extracts were preincubated with the
anti-p65/RelA antibody (lane 10), thus leading to the positive
identification of NF-B in the retarded protein-oligonucleotide complex. Therefore, the EMSA appeared to be a suitable
assay to study the DNA-binding activity of NF-B. As shown in
Fig. 6A, treatment of either pkr⫹/⫹(EX12) or pkr0/0(EX12)
MEF with dsRNA led to the appearance in the nuclear extracts
of NF-B with similar DNA-binding activity that did not re-

quire the presence of PKR (Fig. 6A, compare lanes 3 and 4
with lanes 8 and 9). Furthermore, cells treated with TNF-␣
displayed a similar DNA-binding activity that was independent
of PKR (lanes 5 and 10). With either dsRNA or TNF-␣ treatment, the induced DNA-binding activity failed to form on an
oligonucleotide probe with a single nucleotide substitution
(Fig. 6A, second panel from the bottom), further demonstrating that NF-B is the major (and possibly the only) DNAbinding activity in the complex. The corresponding cytosolic
extracts demonstrated the presence of PKR only in the pkr⫹/⫹
(EX12) but not in the pkr0/0(EX12) MEF (bottom panel).
The results presented in Fig. 2 to 6A contrast with the
findings of others (11, 76, 79), who reported that fibroblasts
deficient in PKR failed to respond to dsRNA with NF-B
activation. To investigate whether the different modes of
dsRNA delivery used by us and by others are responsible for
these differences, we compared the responses of MEF either to
10 g of pI-pC per ml in the presence of Lipofectin or to 100
or 500 g of pI-pC per ml without Lipofectin (as used by
Zamanian-Daryoush et al. 79). Using the EMSA, we observed
that both in the presence and in the absence of Lipofectin,
dsRNA was able to induce the NF-B DNA-binding activity in
the PKR-containing and in the PKR-deficient cells (Fig. 6B).
The dsRNA-induced accumulation of the mRNA for beta
interferon occurs in the absence of PKR. Previously, Yang et
al. (76) and Chu et al. (11) found that dsRNA (applied without
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FIG. 5. dsRNA- and TNF-␣-induced specific DNA-binding activity
of NFB. pkr⫹/⫹(EX12) MEF were treated with Lipofectin alone
(lanes Co), with pI-pC (10 g/ml) in the presence of Lipofectin (lanes
dsRNA), or with TNF-␣ (lanes TNF). At 3 h after either Lipofectin or
dsRNA treatments or 20 min after the TNF-␣ treatment, the cells were
harvested and nuclear extracts were prepared as described in Materials
and Methods. EMSAs were performed as described in Materials and
Methods. Where indicated, a 100-fold molar excess of either the specific NF-B-binding nonlabeled oligonucleotide (specific competitor)
or a p53-binding nonlabeled oligonucleotide (nonspecific competitor)
was added to the binding-reaction mixtures for 10 min before the
addition of the specific 32P-labeled NF-B-binding oligonucleotide. In
the last lane, the undiluted anti-p65/RelA (C-20 from Santa Cruz)
antibody was added in 1/10 of the final reaction volume for 10 min
before the addition of the specific 32P-labeled NF-B-binding oligonucleotide. Addition of several irrelevant antibodies did not interfere
with the specific binding of NF-B to DNA, demonstrating the specificity of the anti-p65/RelA antibody-induced supershift (data not
shown).
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the aid of a lipophilic internalization vehicle) was severely
impaired in its ability to induce beta interferon expression in
the pkr0/0(EX2⫹3) MEF (76) or in a pkr0/0(EX2⫹3) 3T3-like
fibroblast cell line (11). We investigated whether PKR might
be required for the dsRNA-induced expression of beta interferon when dsRNA was delivered with the aid of Lipofectin.
Treatment with dsRNA for 4 h led to the accumulation of the
mRNA for beta interferon (as measured in an RNase protection assay) in the pkr⫹/⫹(EX2⫹3), pkr0/0(EX2⫹3), pkr⫹/⫹
(EX12), and pkr0/0(EX12) MEF (Fig. 7A, lanes 3, 6, 9, and 12).
Determination of the actual fold activation was impossible due
to the undetectable levels of beta interferon mRNA expression
in the control cells (lanes 1, 4, 7, and 10). Similar to beta
interferon, the mRNAs for two inflammatory cytokines, IL-6
and TNF-␣, were also induced by dsRNA in the pkr⫹/⫹
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FIG. 7. Expression of dsRNA-induced genes independent of the
presence or absence of PKR. (A) MEF with the indicated genotype
were left untreated (lanes Control) or were treated with Lipofectin
alone (lanes LF) or with pI-pC (10 g/ml) in the presence of Lipofectin (lanes dsRNA). At 4 h later, the cells were harvested, total RNA
was prepared, and the steady-state levels of expression of multiple
cytokines were assessed in a multiprobe RNase protection assay as
described in Materials and Methods. The levels of the mRNAs for the
ribosomal protein L32 and the housekeeping gene glyceraldehyde-3phosphate dehydrogenase (GAPDH) were used as controls for RNA
amount and loading. TGF␤3, transforming growth factor ␤3; MIF,
migration inhibitory factor. (B) MEF with the indicated genotype were
treated with Lipofectin alone (⫺) or with pI-pC (10 g/ml; dsRNA) in
the presence of Lipofectin (⫹). At 24 h later, the presence of IL-6 in
the conditioned culture medium was determined as described in Materials and Methods. Error bars represent standard deviation from
experimental points in triplicate.

(EX2⫹3), pkr0/0(EX2⫹3), pkr⫹/⫹(EX12), and pkr0/0(EX12)
MEF (lanes 3, 6, 9, and 12). In contrast, the mRNAs encoding
the cytokines transforming growth factor ␤3 (TGF-␤3) and
migration inhibitory factor (MIF) were expressed constitutively in the MEF and were not induced by dsRNA, demonstrating the specificity of the dsRNA response (lanes 3, 6, 9,
and 12). None of these mRNAs was induced by Lipofectin
alone (lanes 2, 5, 8, and 11). We concluded, therefore, that
PKR was not required for the dsRNA-induced expression of
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FIG. 6. dsRNA-induced specific DNA-binding activity of NFB independent of the presence or the absence of PKR. (A) pkr⫹/⫹(EX12)
or pkr0/0(EX12) MEF were treated with Lipofectin alone (lanes Control), with pI-pC (10 g/ml) in the presence of Lipofectin (lanes
dsRNA), or with TNF-␣ (lanes TNF). At the indicated times after the
treatment, the cells were harvested and EMSAs were performed as in
the experiment in Fig. 5. A specific 32P-labeled NF-B-binding oligonucleotide (top panel) or 32P-labeled oligonucleotide bearing a singlebase substitution (Santa Cruz) (middle panel) was used. The asterisk
depicts the position in the middle panel that corresponds to the position of the NF-B-DNA complex in the upper panel. The corresponding cytosolic extracts (see Materials and Methods) were used in an
immunoblot procedure to demonstrate the absence of PKR in the
pkr0/0(EX12) MEF (bottom panel). (B) pkr⫹/⫹(EX12) or pkr0/0(EX12)
MEF were left untreated (lanes Control) or were treated with pI-pC
(100 or 500 g/ml) in the absence of Lipofectin (lanes dsRNA), with
Lipofectin alone (lane LF), or with pI-pC (10 g/ml) in the presence
of Lipofectin (lane LF⫹dsRNA). At the indicated times after the
treatment, the cells were harvested and EMSAs were performed as in
the experiment in Fig. 5.
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beta interferon mRNA or of IL-6 and TNF-␣ mRNAs. PKR
was also not required for the dsRNA-induced accumulation of
the mRNA for the NF-B-dependent antiapoptotic gene iap-2
(data not shown).
PKR contributes, in mouse fibroblasts, about 50% of the
overall inhibition of translation in response to dsRNA (the
other 50% being contributed by the 2-5 oligoadenylate synthase/RNase L system) (26). It was therefore reasonable to
speculate that activated PKR may negatively affect gene expression via its inhibitory action on protein synthesis. To address this question, we employed a highly sensitive enzymelinked immunosorbent assay for the detection of IL-6 and
determined whether the presence or absence of PKR affects
the expression and/or secretion of this cytokine. As shown in
Fig. 7B, the levels of IL-6 in the culture medium were markedly
elevated 24 h after the treatment with dsRNA in the pkr⫹/⫹
(EX2⫹3), pkr0/0(EX2⫹3), pkr⫹/⫹(EX12), and pkr0/0(EX12)
MEF. We were unable, therefore, to discern a clear pattern of
PKR involvement in the production of IL-6 in response to
dsRNA.
The dsRNA-induced activation of NF-B does not require
RNase L. The OAS/2-5A/RNase L system is a dsRNA-activated signal transduction cascade that parallels the PKR/
eIF-2␣ cascade (54). In mouse fibroblasts, PKR and RNase L
are solely required and sufficient for the dsRNA-induced inhibition of translation, since cells with a combined deficiency in
both genes fail to inhibit translation when challenged with
dsRNA (26). We considered the possibility that RNase L
might be involved in mediating the dsRNA-induced signaling
to NF-B. To test this hypothesis, we employed 3T3-like fibroblast cell lines with pkr⫹/⫹/rnasel⫹/⫹, pkr⫹/⫹/rnasel⫺/⫺, and
pkr⫺/⫺/rnasel⫺/⫺ genotypes (84). Both the cells with a single
RNase L deficiency and the cells with a combined PKR and
RNase L deficiency displayed dsRNA-induced degradation of
IB-␤ in a manner similar to the wild-type cells (Fig. 8, com-

FIG. 9. dsRNA-induced nuclear translocation of NFB in cells deficient in RNase L or both RNase L and PKR. 3T3-like fibroblast cell
lines with pkr⫹/⫹/rnasel⫹/⫹, pkr⫹/⫹/rnasel⫺/⫺, and pkr⫺/⫺/rnasel⫺/⫺ genotypes were treated with Lipofectin alone (Control) or with pI-pC (10
g/ml) in the presence of Lipofectin (dsRNA). At 3 h after treatment,
the cells were fixed and immunostained with an antibody recognizing
the p65/RelA subunit of NFB as in the experiment in Fig. 3.

pare lanes 1 to 3 with lanes 4 to 6). Furthermore, in each cell
line, NF-B translocated to the nucleus in response to dsRNA
treatment (Fig. 9). We concluded, therefore, that neither PKR
nor RNase L is a critical component in mediating the dsRNAinduced signaling to NF-B.
DISCUSSION
The most important result of this study is the demonstration
of a novel response of cells to viral dsRNA that is independent
of the dsRNA-activated PKR. Surprisingly, we found that this
response includes the dsRNA-induced activation of NF-B
(Fig. 2 to 6, 8, and 9) and the production of beta (“fibroblast”)
interferon (Fig. 7A), two critical components of innate immunity that were previously described by others to depend, in
fibroblasts, on the presence of PKR (11, 76, 79). We argue that
the activation of NF-B by dsRNA does not require PKR
because the following critical steps of activation of this transcription factor by dsRNA were found to be unimpaired in
cells lacking PKR: (i) the phosphorylation, polyubiquitinylation, and degradation of IB (Fig. 2); (ii) the nuclear translocation of NF-B (Fig. 4); (iii) the specific DNA-binding activity
of NF-B (Fig. 6); and (iv) the induction of NF-B-dependent
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FIG. 8. dsRNA-induced degradation of IB-␤ in cells deficient in
RNase L or both RNase L and PKR. 3T3-like fibroblast cell lines with
pkr⫹/⫹/rnasel⫹/⫹, pkr⫹/⫹/rnasel⫺/⫺, and pkr⫺/⫺/rnasel⫺/⫺ genotypes
were treated with Lipofectin alone (lanes Control) or with pI-pC (10
g/ml) in the presence of Lipofectin (lanes dsRNA). At the indicated
times after treatment, the cells were harvested and the steady-state
levels of IB-␤ were assessed as in the experiment in Fig. 1A. The
membranes were stripped and reprobed with an anti-PKR antibody
(D-20).
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genes, such as the genes for beta interferon, IL-6, TNF-␣, and
IAP-2 (Fig. 7 and data not shown) (for an extended list of
established NF-B-dependent genes, see reference 42 and references therein).
Evidence for the existence of previously unsuspected novel
cellular sensors for dsRNA and their implication in the antiviral response and postviral immunopathic diseases. Figure 10
summarizes the model we propose for the ability of viral
dsRNA to trigger both pro- and antiapoptotic cellular programs. The apoptotic program requires the activities of PKR
and RNase L (see below). Based on our findings that the
antiapoptotic program of innate antiviral immunity (which
proceeds through the activation of NF-B) is independent of
the presence of PKR and RNase L, we postulate the existence
of novel, yet to be identified sensors for dsRNA that are different from PKR and, probably, OAS. It is possible that the
same novel dsRNA-sensing machinery also mediates the virusinduced activation of the SAPK (i.e., JNK and p38 MAP kinase), since the dsRNA-induced activation of SAPK can also
proceed in the absence of PKR and RNase L (26). The activation of NF-B is thought to mediate cell survival in response
to viral infection (48). The combined activation of SAPK and
NF-B, in turn, is probably involved in the production of alpha,
beta, and omega interferons and other alarmones, including
inflammatory mediators such as IL-6 and TNF-␣. Concerning
the role of inflammatory cytokines induced by dsRNA, we
hypothesize that the PKR-independent, dsRNA-induced activation of the SAPK- and NF-B-dependent signal transduction
pathways (which lead to the expression of inflammatory mediators [reference 26 and this study]) may be an important contributor not only to the acute inflammation but also to the
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chronic inflammation caused by persistent viral infections.
Enteroviruses (such as coxsackievirus, poliovirus, echovirus,
EMCV, and other members of the picornavirus family; for a
review, see reference 47) are known to cause debilitating and
long-lasting postviral immunopathic muscle diseases. For instance, the coxsackievirus-induced mouse model of inflammatory myopathy is associated with the presence in the affected
muscle of persistent dsRNA viral sequences (60). Wessely et
al. (71) have used transgenic expression of both the plus and
minus strands of a replication-restricted coxsackievirus genome in the mouse heart to provide experimental evidence
that coxsackievirus dsRNA can cause dilated cardiomyopathy
in the absence of infectious viral progeny. Heart failure due to
dilated cardiomyopathy accounts for ⬃45% of the cardiac
transplantations performed in the United States (23). An investigation of the involvement of dsRNA-induced SAPK- and
NF-B-dependent signal transduction pathways in virus-induced inflammatory myopathies may therefore have important
therapeutic consequences.
Is there an irreconcilable difference between our finding
that PKR is not required for the dsRNA-induced signaling to
NF-B and interferon production and the results of others
who have reached the opposite conclusion? In our opinion,
there is not an irreconcilable difference between our results
and those of other workers (11, 76, 79). The best evidence for
this is the indication (already contained in the work of Yang et
al. 76) that PKR is not involved in mediating the innate immunity to viruses at the level of the organism. In that study, the
authors found that injection of dsRNA peritoneally into either
PKR-containing or PKR-deficient mice induced similar levels
of beta interferon mRNA expression in the spleens of the mice
of either genotype (76). However, we are currently unable to
offer an explanation for the differences between our results and
the results of Williams and coworkers and Karin and coworkers (11, 76, 79) in experiments performed in MEF in vitro.
Still, could PKR, under specific circumstances, play a role in
the activation of NF-B by viral dsRNA? Several recent reports indicate that this is possible. It has been discovered that
when overexpressed in cells, PKR has the potential to activate
IKK2/␤ (6, 11, 19). Interestingly, a kinase-deficient mutant of
PKR retained the ability to activate IKK2/␤ upon overexpression, suggesting that in this case, PKR exerted a kinase-independent action whose nature is unknown (6, 11). It remains to
be elucidated whether this phenomenon has biological relevance.
What is the major role of PKR (and of the OAS/RNase L
system) in response to virus infections? Obviously, the most
relevant answers to this question should come from the PKR
and RNase L genetic knockouts. The most profound defects
we observed in fibroblasts that are deficient in PKR, RNase L,
or both PKR and RNase L were the reduced ability of dsRNA
to inhibit translation (26) and to trigger apoptosis (our unpublished observations). These results alone establish both PKR
and OAS/RNase L system as important mediators of the proapoptotic cellular program in response to virus infections. Additional confirmation of the proapoptotic role of PKR and
RNase L comes from the attempts of several laboratories to
establish cell lines overexpressing either of these two enzymes.
Overexpression of either PKR or RNase L potentiates apoptosis in response to dsRNA (2, 3, 7, 9, 78). Interestingly, PKR-
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FIG. 10. Model for the diverse actions of viral dsRNA at the cellular level. See explanations in the text.
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